Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-032366
Filing Date
2024-10-29
Accepted
2024-10-29 08:19:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20241029_defa14a.htm DEFA14A 44310
2 EXHIBIT 99.1 ex_739267.htm EX-99.1 16252
3 nb01.jpg GRAPHIC 10980
  Complete submission text file 0001437749-24-032366.txt   76804
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 241402759
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)